HCA Healthcare Analyst Price Targets

Wall Street analyst price targets and consensus rating for HCA Healthcare (HCA).

Price Target Range — 9 Quarters

Analyst Consensus — 22 Analysts

15Buy

6Hold

1Sell

Consensus RatingBuy# Analysts22Avg. Consensus PT$476Upside to Avg. PT+8.3%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 7, 2026	RBC Capital	Ben Hendrix	PT Raise	Outperform	$435→$496
Sep 23, 2026	BMO Capital	Sean Dodge	Initiate	Outperform	$495
Sep 18, 2026	Leerink Partners	Whit Mayo	Maintained	Outperform	$492
Sep 8, 2026	RBC Capital	Ben Hendrix	Maintained	Outperform	$435
Aug 20, 2026	JP Morgan	Benjamin Rossi	PT Cut	Neutral	$490→$425
Aug 3, 2026	Wells Fargo	Stephen Baxter	PT Raise	Equal-Weight	$369→$381
Jul 28, 2026	Goldman Sachs	Scott Fidel	PT Cut	Buy	$558→$485
Jul 28, 2026	Mizuho	Ann Hynes	PT Cut	Outperform	$525→$475
Jul 27, 2026	UBS	A.J. Rice	PT Cut	Buy	$635→$579
Jul 27, 2026	Morgan Stanley	Craig Hettenbach	PT Cut	Underweight	$425→$380
Jul 27, 2026	RBC Capital	Ben Hendrix	Maintained	Outperform	$435
Jul 27, 2026	Truist Securities	David Macdonald	PT Cut	Buy	$535→$495
Jul 27, 2026	Oppenheimer	Michael Wiederhorn	PT Cut	Outperform	$520→$485
Jul 27, 2026	Keybanc	Matthew Gillmor	PT Cut	Overweight	$475→$435
Jul 27, 2026	Baird	Michael Ha	PT Cut	Neutral	$396→$393
Jul 27, 2026	Barclays	Andrew Mok	PT Cut	Equal-Weight	$402→$387
Jul 16, 2026	Barclays	Andrew Mok	PT Cut	Equal-Weight	$427→$402
Jul 15, 2026	RBC Capital	Ben Hendrix	PT Cut	Outperform	$534→$435
Jul 14, 2026	Keybanc	Matthew Gillmor	PT Cut	Overweight	$510→$475
Jul 13, 2026	Wells Fargo	Stephen Baxter	PT Cut	Equal-Weight	$436→$428

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
RBC Capital Maintains Outperform on HCA Healthcare, Raises Price Target to $496

RBC Capital analyst Ben Hendrix maintains HCA Healthcare (NYSE:HCA) with a Outperform and raises the price target from $435 to $496.

Benzinga Newsdesk

This HCA Healthcare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

Analysts initiated bullish coverage on HCA, GRDN, TTC, MRVL and PLSE, setting price targets of $495, $52, $120, $270 and $70.

Avi Kapoor

PRO
BMO Capital Initiates Coverage On HCA Healthcare with Outperform Rating, Announces Price Target of $495

BMO Capital analyst Sean Dodge initiates coverage on HCA Healthcare (NYSE:HCA) with a Outperform rating and announces Price Target of $495.

Benzinga Newsdesk

PRO
RBC Capital Reiterates Outperform on HCA Healthcare, Maintains $435 Price Target

RBC Capital analyst Ben Hendrix reiterates HCA Healthcare (NYSE:HCA) with a Outperform and maintains $435 price target.

Benzinga Newsdesk

PRO
JP Morgan Maintains Neutral on HCA Healthcare, Lowers Price Target to $425

JP Morgan analyst Benjamin Rossi maintains HCA Healthcare (NYSE:HCA) with a Neutral and lowers the price target from $490 to $425.

Benzinga Newsdesk

PRO
Wells Fargo Maintains Equal-Weight on HCA Healthcare, Raises Price Target to $381

Wells Fargo analyst Stephen Baxter maintains HCA Healthcare (NYSE:HCA) with a Equal-Weight and raises the price target from $369 to $381.

Benzinga Newsdesk

HCA Healthcare Inc

뉴스

파트너 / 기고자

벤징가 글로벌

HCA Healthcare Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
RBC Capital Maintains Outperform on HCA Healthcare, Raises Price Target to $496

This HCA Healthcare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

PRO
BMO Capital Initiates Coverage On HCA Healthcare with Outperform Rating, Announces Price Target of $495

PRO
RBC Capital Reiterates Outperform on HCA Healthcare, Maintains $435 Price Target

PRO
JP Morgan Maintains Neutral on HCA Healthcare, Lowers Price Target to $425

PRO
Wells Fargo Maintains Equal-Weight on HCA Healthcare, Raises Price Target to $381

People Also Watch

People Also Watch

HCA Healthcare Inc

뉴스

파트너 / 기고자

벤징가 글로벌

HCA Healthcare Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRORBC Capital Maintains Outperform on HCA Healthcare, Raises Price Target to $496

This HCA Healthcare Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday

PROBMO Capital Initiates Coverage On HCA Healthcare with Outperform Rating, Announces Price Target of $495

PRORBC Capital Reiterates Outperform on HCA Healthcare, Maintains $435 Price Target

PROJP Morgan Maintains Neutral on HCA Healthcare, Lowers Price Target to $425

PROWells Fargo Maintains Equal-Weight on HCA Healthcare, Raises Price Target to $381

People Also Watch

People Also Watch

PRO
RBC Capital Maintains Outperform on HCA Healthcare, Raises Price Target to $496

PRO
BMO Capital Initiates Coverage On HCA Healthcare with Outperform Rating, Announces Price Target of $495

PRO
RBC Capital Reiterates Outperform on HCA Healthcare, Maintains $435 Price Target

PRO
JP Morgan Maintains Neutral on HCA Healthcare, Lowers Price Target to $425

PRO
Wells Fargo Maintains Equal-Weight on HCA Healthcare, Raises Price Target to $381